CHI3L1 and glioblastoma: To our knowledge, only Kazakova et al. [42] have described both tumor and serum YKL-40 in patients with glioblastoma (n = 14) and suggested that serum YKL-40 correlated positively with tissue YKL-40 expression, although it was not clear how this analysis was performed.